Clinical Trial Update: A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating peginterferon alfa-2a with or without ribavirin in chronic hepatitis D was completed, and results were posted in July 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Copegus (ribavirin)
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis D, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-07-15